文献速递心脏核医学

Tc-99m PYP/Tl-201双同位素SPECT在疑似心脏淀粉样变中的应用

Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis.
PubMed 文献 · J Nucl Cardiol · 2019-06-06

该研究在112例疑似心脏淀粉样变患者中同期采集Tc-99m PYP/Tl-201双同位素SPECT,比较单同位素与双同位素SPECT的视觉判读和H/CL定量。结果显示双同位素SPECT减少了无淀粉样变和AL患者的可疑判读比例,提高了观察者间一致性,并提高了检出ATTR的AUC。

要点

  • 双同位素SPECT减少无淀粉样变和AL患者视觉判读为可疑的比例。
  • 双同位素SPECT提高视觉评估的观察者间一致性。
  • 双同位素SPECT视觉评估和H/CL定量检出ATTR的AUC均高于单同位素。

核心结论

  • Tc-99m PYP/Tl-201双同位素SPECT较单同位素SPECT改善ATTR与AL淀粉样变的视觉鉴别。
  • 双同位素SPECT的视觉评估与H/CL定量对ATTR和AL的区分能力相似。

研究设计与样本

  • 在112例疑似心脏淀粉样变患者中同期采集Tc-99m PYP/Tl-201双同位素SPECT。
  • 由两名观察者先后对单同位素和双同位素SPECT进行视觉判读。
  • 比较ATTR、AL和无淀粉样变三组间单同位素与双同位素SPECT的H/CL比值。

主要发现

  • 112例中包括39例ATTR、26例AL和47例无淀粉样变患者。
  • 无淀粉样变患者视觉判读为可疑的比例双同位素SPECT为2%、单同位素为19%(P = 0.02)。
  • AL患者视觉判读为可疑的比例双同位素SPECT为8%、单同位素为35%(P = 0.04)。
  • AL和无淀粉样变患者的H/CL在单同位素和双同位素SPECT下均低于ATTR患者(P < 0.05)。
  • 双同位素SPECT视觉评估检出ATTR的AUC为0.94、H/CL定量为0.95,单同位素分别为0.84(P = 0.001)和0.92(P = 0.02)。

关键数值与推荐

  • 视觉判读为可疑的比例:无淀粉样变组双同位素2% vs 单同位素19%(P = 0.02)。
  • 视觉判读为可疑的比例:AL组双同位素8% vs 单同位素35%(P = 0.04)。
  • 检出ATTR的AUC:双同位素视觉评估0.94、H/CL定量0.95;单同位素视觉评估0.84(P = 0.001)、H/CL定量0.92(P = 0.02)。

临床怎么用

  • 对疑似心脏淀粉样变患者,可采用Tc-99m PYP/Tl-201双同位素SPECT辅助区分ATTR与AL。
  • 双同位素SPECT可减少无淀粉样变和AL患者被判读为可疑的情况。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Assessment of myocardial uptake of Tc-99m-pyrophosphate (Tc-99m PYP) is pivotal in distinguishing transthyretin-associated cardiac amyloidosis (ATTR) from light chain amyloid (AL). It is often difficult to differentiate myocardial uptake from blood pool radioactivity with planar imaging or SPECT. We studied whether simultaneous dual-isotope Tc-99m PYP/Tl-201 SPECT improves assessment of Tc-99m PYP uptake compared to single-isotope SPECT. METHODS: Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT was acquired in 112 patients studied for possible cardiac amyloidosis. Visual interpretation was performed by two observers on single-isotope followed by dual-isotope SPECT. Heart-to-contralateral lung ratio (H/CL) of myocardial counts quantified by single-isotope and dual-isotope SPECT was compared between ATTR, AL, and no amyloidosis groups. RESULTS: In 112 patients (39 ATTR and 26 AL patients, and 47 no amyloidosis), a lower proportion of no amyloidosis and AL patients were classified visually as equivocal with dual-isotope SPECT compared to single-isotope SPECT (2% vs 19%, P = 0.02 and 8% vs 35%, P = 0.04, respectively). H/CL measurements with single-isotope and dual-isotope were lower in AL and no amyloidosis patients vs ATTR patients (P < 0.05). Interobserver agreement of visual assessment was improved with dual-isotope SPECT (P = 0.03). AUCs for detection of ATTR by visual assessment and H/CL quantification were higher with dual-isotope (0.94 and 0.95, respectively) compared to single-isotope SPECT (0.84, P = 0.001 and 0.92, P = 0.02). CONCLUSION: Tc-99m PYP/Tl-201 SPECT improves visual differentiation of ATTR and AL amyloidosis compared to single-isotope SPECT. Visual assessment and H/CL quantitation with dual-isotope SPECT provide similar discrimination between patients with ATTR and AL amyloidosis.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Tamarappoo B, Otaki Y, Manabe O, et al. Simultaneous Tc-99m PYP/Tl-201 dual-isotope SPECT myocardial imaging in patients with suspected cardiac amyloidosis. J Nucl Cardiol. 2019. PMID: 31172386. doi:10.1007/s12350-019-01753-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。